Study Demonstrates The Benefits Of Mammography In Women Under 50

October 03, 1997

Women under 50 benefit from screening mammography as much as women over 50, a University of Chicago study reports.

Results of this latest study were presented October 22 at the American Society for Therapeutic Radiology and Oncology's (ASTRO) annual meeting in Orlando, FL.

Presenting the study was Dr. Jeffrey Bradley, lead study author from the University of Chicago.

Dr. Bradley's study focused on 869 women who were both under 50 and over 50. He said the study indicated that screening mammography was effective for all the age groups represented. "The tumors that were detected through mammography were generally smaller and less appeared aggressive under the microscope than those tumors that were detected through physical exams," Dr. Bradley said.

Mammography can detect tumors in the breast which are too small to feel, Dr. Bradley said, which makes it an effective method for detecting breast cancer early.

Dr. Bradley also said that the treatment results for women whose tumors were detected through mammography were better, because the tumors were smaller, and, therefore, easier to treat.

Earlier this year, the American Cancer Society and the American College of Radiology released guidelines that recommend annual screening mammography for women 40 and over. The National Cancer Institute also issued guidelines recommending screening mammography for women 40-49. In so doing, NCI reinstated the support for screening this age group, which it withdrew several years ago.

Each year more than 180,000 women will be diagnosed with breast cancer and studies have shown that when found early the disease is treated most successfully. October is National Breast Cancer Awareness Month.

The American Society for Therapeutic Radiology and Oncology (ASTRO) is the largest radiation oncology society in the world, with some 4,000 members. As a leading organization in radiation oncology, biology and physics, the society's goals are to advance the scientific basis of radiation therapy and to extend the benefits of radiation therapy to those with cancer.

American Roentgen Ray Society

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to